Abbott Laboratories 2013 Annual Report Download - page 39

Download and view the complete annual report

Please find page 39 of the 2013 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 76

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76

ABBOTT 2013 ANNUAL REPORT
37
CONSOLIDATED BALANCE SHEET
(dollars in millions)
December 31 2013 2012
Liabilities and Shareholders’ Investment
Current Liabilities:
Short-term borrowings $ 3,164 $ 2,082
Trade accounts payable 1,026 1,797
Salaries, wages and commissions 906 1,428
Other accrued liabilities 3,500 6,788
Dividends payable 341 221
Income taxes payable 175 655
Current portion of long‑term debt 9 309
Current liabilities held for disposition 386 —
Total Current Liabilities 9,507 13,280
Long‑term Debt 3,388 18,085
Post‑employment Obligations and Other Long‑term Liabilities 4,784 9,057
Non‑current Liabilities Held for Disposition 7 —
Commitments and Contingencies
Shareholders’ Investment:
Preferred shares, one dollar par value
Authorized — 1,000,000 shares, none issued — —
Common shares, without par value
Authorized — 2,400,000,000 shares
Issued at stated capital amount —
Shares: 2013: 1,685,827,096; 2012: 1,675,930,484 12,048 11,755
Common shares held in treasury, at cost —
Shares: 2013: 137,728,810; 2012: 99,262,992 (6,844) (5,591)
Earnings employed in the business 21,979 24,151
Accumulated other comprehensive income (loss) (2,012) (3,594)
Total Abbott Shareholders’ Investment 25,171 26,721
Noncontrolling Interests in Subsidiaries 96 92
Total Shareholders’ Investment 25,267 26,813
$42,953 $67,235
The accompanying notes to consolidated financial statements are an integral part of this statement.